Medyria develops sensor-tipped microcatheters that measure blood flow velocity for coronary diagnosis. It has raised CHF 3.5 million to obtain FDA clearance and prepare the US launch of PyCath.
- Announced on
- Round
- Undisclosed round
- Amount
- CHF 3.5 M
- Location
- Winterthur, canton of Zurich
- Sector
- Health & medtech
Investors
The investors were not named in the announcement.
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic